ERT2-CRE-ERT2 Lentiviral Vector (Bacteriophage P1) (pPromoter)
| Cat. No. | LV010155 |
| Name | ERT2-CRE-ERT2 Lentiviral Vector (Bacteriophage P1) (pPromoter) |
| Unit | 1.0 μg |
| Description |
ERT2-Cre-ERT2 fusion protein of a tamoxifen-regulated form of Cre recombinase and two estrogen receptor T2 (ERT2) genes. Cre recombinase is a Type I topoisomerase from P1 bacteriophage that catalyzes site-specific recombination of DNA between loxP sites. |
| Applications |
abm recommends using Cat# G074, Lentifectin™ in conjunction with one of the following packaging mixes. The suggested packaging mix for this vector is Cat# LV003, 2nd Generation Packaging Mix. Alternatively, you can also use Cat# LV053, 3rd Generation Packaging Mix |
| Storage Condition |
10mM Tris-HCI, 1mM EDTA, pH8.0 |
| Material Citation | If use of this material results in a scientific publication, please cite the material in the following manner: Applied Biological Materials Inc, Cat. No. LV010155 |
Print/Download Datasheet
Search CoA here
Other
There are no FAQs for this product yet!
- Chen, Z., Yu, D., Owonikoko, T. K., Ramalingam, S. S., & Sun, S.-Y. (2021). Induction of SREBP1 degradation coupled with suppression of SREBP1-mediated lipogenesis impacts the response of EGFR mutant NSCLC cells to osimertinib. Oncogene, 40(49), 6653–6665. https://doi.org/10.1038/s41388-021-02057-0
This product has no review yet.